Quantcast

Latest autoimmune diseases Stories

2014-08-01 08:26:41

NEW YORK, Aug. 1, 2014 /PRNewswire/ -- Beginning on August 1, 2014, Crohn's and Colitis Awareness Month will be observed for the first time in New York State thanks to a resolution passed by the New York State legislature in June, reported the Crohn's & Colitis Foundation of America (CCFA). There are more than 1.4 million Americans living with Crohn's disease and ulcerative colitis, which are known collectively as inflammatory bowel diseases (IBD). "We applaud Governor Andrew...

2014-07-31 23:23:12

A new memoir by Zoe Chloe Douglas, now available in e-book and hardcover versions, documents one woman’s experience with Ulcerative Colitis, a common autoimmune disorder. San Diego, CA (PRWEB) July 31, 2014 "The Mirror Inside: A Journey to Finding Answers to Ulcerative Colitis from Within" by Zoe Chloe Douglas can be downloaded for Kindle at http://amzn.to/1nUxRa3, purchased in hardcover format at http://amzn.to/Uywu5H or downloaded for Barnes & Noble Nooks at...

2014-07-31 16:27:33

OTTAWA, July 31, 2014 /CNW/ - Health Canada today released the July 2014 issue of the Canadian Adverse Reaction Newsletter (CARN). This issue includes an article on the anti-cancer drug cisplatin and the risk of blockage of the aorta, the body's main artery. It also includes an article on hydroxychloroquine, a drug used for rheumatoid arthritis, lupus, and malaria, and the risk of developing low blood sugar; and a case presentation on a suspected interaction between efavirenz, an...

2014-07-30 23:07:26

ResearchMoz.us include new market research report "China Diagnostic Reagent Industry Report, 2013-2016" to its huge collection of research reports. Complete Report - http://www.researchmoz.us/china-diagnostic-reagent-industry-report-2013-2016-report.html. Albany, NewYork (PRWEB) July 30, 2014 With the accelerated aging of the Chinese population, the increase of personal health expenditure as well as the improved medical care facilities and government health care system, China...

2014-07-30 04:21:20

CAMBRIDGE, Mass. and HERZLIYA PITUACH, Israel, July 30, 2014 /PRNewswire/ -- Immune Pharmaceuticals Inc. (OTCQX and NASDAQ OMX First North Premier, Stockholm: "IMNP."; "Immune" or "the Company") announces today that it has initiated the screening of patients for a Phase II proof of concept clinical trial exploring the safety and efficacy of bertilimumab in the treatment of moderate to severe bullous pemphigoid. This open-label trial will enroll 10-15 patients who will receive two...

2014-07-29 16:26:15

Researchers Look to Target Gut Microbiome for Treatment and Prevention of Crohn's Disease and Ulcerative Colitis NEW YORK, July 29, 2014 /PRNewswire/ -- Early findings from a major research initiative of the Crohn's & Colitis Foundation of America (CCFA) suggest that specific bacteria play a central role in Crohn's disease and ulcerative colitis (UC), also known as inflammatory bowel diseases (IBD). The evidence raises the possibility of developing new treatments to target the...

2014-07-24 04:21:22

NEW YORK, July 24, 2014 /PRNewswire/ -- Lyfebulb, the International Pemphigus Pemphigoid Foundation (IPPF) and Immune Pharmaceuticals Inc. (OTCQX and NASDAQ OMX First North Premier, Stockholm: "IMNP."; "Immune" or "the Company"), announced a collaboration to increase awareness of unmet needs in treating bullous pemphigoid last night at an event attended by more than sixty patients, physicians, scientists and other interested parties. Lyfebulb is a health and wellness company dedicated...

2014-07-23 08:27:58

What Will Your Challenge Be? NEW YORK, July 23, 2014 /PRNewswire/ -- The Crohn's & Colitis Foundation of America's endurance training and fundraising program, Team Challenge, is thrilled to unveil its upcoming race portfolio with 11 great endurance events scheduled this winter including: -- TriRock San Diego - September 21 -- IRONMAN Chattanooga - September 28 -- Chicago Marathon - October 14 (limited entries) -- New York Marathon - November 1 (limited entries) --...

2014-07-22 08:32:06

New product offers treatment to significant unmet medical need in supportive cancer care DALLAS and NEW YORK, July 22, 2014 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), a developer of new products for oncology supportive care, announced today that it has received 510(K) marketing clearance from the U.S. Food and Drug Administration (FDA) for ProctiGard(TM), its novel treatment for symptomatic management of rectal mucositis. The Company indicated its development of...

2014-07-21 12:24:51

DANVERS, Mass., July 21, 2014 /PRNewswire/ -- The Scleroderma Foundation is preparing for 600 people from around the world to attend its National Patient Education Conference later this week in Southern California. This unique educational event will be held at the Anaheim Marriot Friday, July 25, through Sunday, July 27. The conference focuses on scleroderma, a mysterious, and sometimes fatal, autoimmune disease that causes a person's body to attack itself by creating too much...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.